COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma

J Dermatolog Treat. 2022 May;33(3):1782-1783. doi: 10.1080/09546634.2020.1822500. Epub 2020 Oct 22.

Authors

M Arenbergerova¹, S Gkalpakiotis¹, P Arenberger¹, A Fialova¹, M Pasek¹

Affiliation

¹ Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.

PMID: 33092421
DOI: 10.1080/09546634.2020.1822500

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Humans
Immune Checkpoint Inhibitors / adverse effects
Melanoma* / drug therapy
Skin Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors